Bio-Rad Laboratories, Inc.
BIO
주식 순위
#2176
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
주가
$352.89
마지막 동기화: 2026-10-16
시가총액
$9.44B
변동 (1일)
-3.34%
변동 (1년)
13.83%
국가
US
거래 Bio-Rad Laboratories, Inc. (BIO)
카테고리
Healthcare
Bio-Rad Laboratories, Inc. (BIO)의 영업이익률
October 2026 기준 영업이익률 TTM: 9.08%
Bio-Rad Laboratories, Inc.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 9.08%입니다. 2023년 말 기준 영업이익률은 12.65%였습니다.
Bio-Rad Laboratories, Inc.의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
| 연도 | 영업이익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 9.08% | -13.36% |
| 2024 | 10.48% | -17.15% |
| 2023 | 12.65% | -26.54% |
| 2022 | 17.22% | 0.58% |
| 2021 | 17.12% | 3.44% |
| 2020 | 16.55% | 66.67% |
| 2019 | 9.93% | -309.49% |
| 2018 | -4.74% | -187.78% |
| 2017 | 5.40% | 110.12% |
| 2016 | 2.57% | -68.89% |
| 2015 | 8.26% | 19.71% |
| 2014 | 6.90% | -13.21% |
| 2013 | 7.95% | -37.70% |
| 2012 | 12.76% | -10.33% |
| 2011 | 14.23% | -3.46% |
| 2010 | 14.74% | 13.82% |
| 2009 | 12.95% | 24.88% |
| 2008 | 10.37% | 12.11% |
| 2007 | 9.25% | -19.35% |
| 2006 | 11.47% | 17.52% |
| 2005 | 9.76% | -2.30% |
| 2004 | 9.99% | -31.25% |
| 2003 | 14.53% | -5.59% |
| 2002 | 15.39% | 12.34% |
| 2001 | 13.70% | 48.91% |
| 2000 | 9.20% | 0.00% |
유사 기업 또는 경쟁사의 영업이익률
| 회사 | 영업이익률 | 영업이익률 차이 | 국가 |
|---|---|---|---|
| 17.03% | -98.12% |
US
|
|
| 17.86% | -98.03% |
IE
|
|
| 22.03% | -97.57% |
US
|
|
| 21.46% | -97.64% |
US
|
|
| 0.00% | - |
DE
|
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.